Results
1
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
1 companies
Kamada
Market Cap: ₪1.5b
Manufactures and sells plasma-derived protein therapeutics.
KMDA
₪25.50
7D
11.5%
1Y
6.0%